# DIabetic Retinopathy Candesartan Trials

> **NCT00252694** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 4717 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** candesartan

## Key facts

- **NCT ID:** NCT00252694
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2008-02
- **Final completion:** 2008-04
- **Target enrollment:** 4717 (ACTUAL)
- **Last updated:** 2014-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252694, "DIabetic Retinopathy Candesartan Trials". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00252694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*